INSIGHTS ON CLINICAL TRIAL DESIGN

• Why Team Integration Makes Or Breaks Marketing Applications

  True team integration transcends basic collaboration, requiring the dismantling of barriers between sponsors and vendors, eliminating departmental silos, and cultivating mutual accountability.

• 5 Common Gaps Between Patient Referral And Screening That Derail Trials

  Up to 40% of clinical trial referrals drop off before screening due to financial, logistical, and administrative hurdles. Streamlining coordination and easing patient burden can boost enrollment.

• Solutions To The Challenges Of Oncology Trials

  This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.

• Is Your Clinical Research Site GCP-Ready?

  By fostering a culture of continuous improvement through internal audits, clinical research sites can identify non-compliance issues and enhance their research practices.

• Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study

  4/17/2025

  This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.

• Ensuring A Diverse Patient Population In Clinical Trials

  12/13/2024

  In 2025, the FDA will require pharmaceutical companies to include diversity action plans (DAPs) for Phase II and pivotal studies.

• Continuous Passive Monitoring's Effect On Sleep Disorder Research

  3/16/2026

  Bridge the gap between clinical sleep studies and real-world behavior. Use continuous, wearable-enabled data to objectively measure daytime sleepiness and improve sleep disorder research.

• Dedicated Community Oncology Sites

  7/29/2026

  Rapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.

• Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy

  3/17/2026

  Bridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.